Long-term survival results of non-small cell lung cancer patients with complete pathological response after neoadjuvant therapy

Background:­ This study aims to investigate the operation-related complications, recurrence frequency, morbidity, mortality and survival rates as well as

In the light of this perspective, in the present study, we aimed to investigated whether the tumor volume affected the survival in patients with

Küçük hücreli dışı akciğer kanseri tanısı olmayan olgular, preoperatif dönemde kemoterapi ve/veya radyoterapi alan olgular, mediastinoskopide mediastinal lenf nodları (N2 ve

Objective: We aimed to determine tumor marker levels in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) at the time of diagnosis, to investigate

This study was approved by University of Health Sciences Turkey, İstanbul Training and Research Hospital Ethics Committee (approval number: 1858, date:

A high local control rate with no major toxicity was obtained by stereotactic ablative body radiotherapy in the patients with medically inoperable early-stage non-small cell

In the current review, recent findings with respect to the role of mainly CYP1A1, CYP1B1, CYP2D6, CYP2E1 and CYP3A4 gene polymorphisms in response to chemotherapy and survival

Even development of cardiac tamponade in SCLC patients, a long-term survival would be achieved if there might be several favorable factors as observed in our patient. RE FE